1. Introduction {#sec0005}
===============

For the past few years, several studies have shown that bacteria present complex transcriptional activity, showing intricate gene expression regulation and envolving multiple classes of transcripts (including sRNAs) ([@bib0250]; [@bib0270]; [@bib0105]; [@bib0165]). In this context, understanding such transcriptomic scenery is essential to get insights on the pathways of a bacterial physiology, metabolism, and adaptation to changing environments. To address this issue, it is vital to assess the expression profile of each transcript, which in turn is the result of the balance established between *de novo* transcription and its degradation at a particular growth context. A multitude of studies have focused on the regulation and mechanisms of transcription initiation and/or on measuring steady-state transcript levels in different bacteria, but only a handful of them explored the global trends of transcripts' molecular stability (some examples: [@bib0285]; [@bib0035]; [@bib0130]; [@bib0025]; [@bib0160]; [@bib0220]; [@bib0175]; [@bib0060]). Although most of these studies revealed a lack of association between several characteristics of a transcript and its decay rate over time (e.g., secondary structures, G + C content, codon composition and transcript length), they further pointed that transcripts' stability could be species-specific and/or be influenced by bacterial growth rates ([@bib0220]) and by a variety of cell signals and external stimuli (reviewed in [@bib0285]). mRNA decay studies have been essentially performed only in extracellular bacteria, which are more undemanding to handle, resulting in a general lack of information for obligate intracellular bacteria.

The high-throughput RNA sequencing (RNA-seq) technology ([@bib0115]) has been applied for complex analyses of the bacterial transcriptome, including gene expression quantification, identification of operons, detection of antisense transcription, characterization of small RNAs and non-coding RNAs, and even the determination of mRNA decay rates ([@bib0075]; [@bib0235]; [@bib0205]; [@bib0240]; [@bib0070]). For the obligate intracellular bacteria *C. trachomatis*, the RNA-seq technology has been successfully applied, for instance, to map all TSSs and to identify novel sRNAs ([@bib0010]), to simultaneously assess the gene's expression of both the bacterium and the host in response to an infection scenario ([@bib0150]), and also to evaluate the impact of culture-derived mutations on the transcriptome ([@bib0050]). The understanding of the transcriptome of *C. trachomatis* holds great interest as this is a highly prevalent human pathogen and a major public health concern. In fact, it is the etiologic agent of the blindness trachoma and constitutes the major bacterial cause of sexually transmitted infections worldwide ([@bib0055]; [@bib0295]). As a member of Chlamydiaceae, this bacterium displays a unique biphasic developmental cycle of about 36--96 h ([@bib0185]) during which, the extracellular and infectious form, the EB, enters the host cell and differentiates into the intracellular and replicative form, the RB. After several rounds of binary fission within a membrane-bound vacuole known as the inclusion, RBs differentiate back into EBs, which are released from the host cell, by lysis or inclusion extrusion, to carry on new infections in neighbouring cells.

Overall, the strains of *C. trachomatis* can be classified into 2 biovars and 15 major serovars according to the polymorphism of the Major Outer Membrane Protein (MOMP, encoded by *ompA*). The trachoma biovar include strains from serovars A-C and D-K, which preferentially infect epithelial cells of the ocular conjunctivae and the ano-urogenital tract, respectively, causing organ-specific diseases ([@bib0210]; [@bib0185]). On the other hand, the LGV biovar include strains from the serovars L1-L3, which also colonize the host through the ano-urogenital tract, but are able to disseminate to the regional draining lymph nodes, via infection of the macrophages ([@bib0225]). To date, investigators are struggling to understand which factors underlie the phenotypic differences, namely, discrepancies in growth rates, routes of infection, cell tropism and disease-outcomes ([@bib0110]; [@bib0275]; [@bib0085]; [@bib0045]; [@bib0135]; [@bib0180]; [@bib0005]; [@bib0080]; [@bib0100]; and reviewed in [@bib0195]). Considering that the genetic dissimilarity among the *C. trachomatis* strains is less than 2%, it has been speculated that differences in the regulation of gene expression also contribute to the above mentioned phenotypic discrepancies. Some studies aiming the evaluation of gene expression differences among *C. trachomatis* strains have been performed, namely, whole transcriptomic analysis focused on a single strain ([@bib0030]; [@bib0010]; [@bib0150]), or multi-strain analyses focused on a restricted set of genes ([@bib0190]; [@bib0040]; [@bib0015]; [@bib0245]; [@bib0095]). Still, intra-strain gene expression dissimilarities observed so far reflect transcripts abundance at discrete moments, and this abundance is completely dependent on the joint action of both the transcription initiation and decay rates ([@bib0125]; [@bib0255]; [@bib0215]; [@bib0155]). To give the first steps towards the understanding of these dual transcriptional dynamics in *C. trachomatis,* we carried out an exploratory global survey regarding the expression level and the decay rate of transcripts in strains representing the two biovars, in an attempt to unveil putative differences that may underlie biovar-specific phenotypes.

2. Materials and methods {#sec0010}
========================

2.1. Cell culture, rifampicin treatment and harvesting {#sec0015}
------------------------------------------------------

*C. trachomatis* E/CS1025-11 and L2b/CS19-08 clinical strains (subjected to minimal culture passages) were independently inoculated into 15 T~25~ flasks of confluent HeLa229 cells monolayers by centrifuging at 2200 rpm for 1 h (34 °C), followed by an incubation stage of 1 h at 37 °C, in a 5% CO~2~ atmosphere. Cell culture medium was then discarded and fresh enriched medium (MEM 10% foetal bovine serum, vitamins, non-essential aminoacids, glucose and 0.5 μg/ml cycloheximide) was added to the cultures. Bacterial cells were allowed to grow at 37 °C with 5% CO~2~, until the mid-phase of the developmental cycle was achieved (20 h and 24 h pi for L2b/CS19-08 and E/CS1025-11, respectively), because the majority of *C. trachomatis* genes are being actively transcribed at this point ([@bib0030]; [@bib0150]) and also because, at this stage carry over mRNA, which would be quickly degraded biasing the decay rate calculations, was found to be no longer present ([@bib0150]). As the estimation of the mid-phase was roughly assessed by microscopic monitoring of inclusions development, we opted by a careful approach by essentially focusing the expression and decay comparative analysis between strains on groups of genes. In fact, a gene-based analysis was solely performed on a discrete manner.

Three sets of five flasks, for each strain, were submitted to different periods of rifampicin treatment (10 μg/ml) − 0 min (T~0~, no treatment), 10 min (T~10~) and 30 min (T~30~) − in order to stop *de novo* RNA synthesis ([@bib0140]; [@bib0170]), and thus, allow the evaluation of the mRNA decay. One T~25~ flask of T~0~, T~10~ and T~30~ sets was immediately harvested by using glass beads, the cell suspension was sonicated for 7 min (Vibra Cell, Bioblock Scientific), for host cells disruption and chlamydial release, submitted to a centrifugation of 7 min at 700 rpm, for cell debris deposit, and finally the supernatant was stored at −20 °C for further DNA extraction. The remaining four T~25~ flasks of T~0~, T~10~ and T~30~ culture sets, were treated with the rifampicin solution, as previously mentioned. Immediately after the respective treatment period, the solution was replaced with a 2:1 solution of RNAprotect™ Bacteria Reagent (Qiagen) and PBS buffer and left for 2 min, to ensure diffusion into the cells for the bacterial RNA preservation during subsequent handling. Again, cultures were harvested, sonicated and centrifuged as previously referred, and the supernadant was immediately submitted to RNA extraction. Note that we intentionally did not treat the cell culture from which DNA would be extracted, because a preliminary assay showed that the RNAprotect™ Bacteria Reagent (Qiagen) degrades DNA (data not shown). We performed two biological replicates for both strains.

2.2. DNA and RNA extraction {#sec0020}
---------------------------

Both nucleic acids were extracted as previously referred ([@bib0095]). Briefly, DNA was extracted by centrifuging the stored (--20 °C) supernatant at 14,000 rpm for 10 min (at 4 °C) and the pellet was resuspended in 200 μl PBS for QIAamp^®^ DNA Mini Kit (Qiagen) extraction, according to manufacturer's instructions. DNA was eluted in 50 μl of AE buffer and stored at −20 °C after A260 nm quantification in a NanoDrop 1000 spectrophotometer (Thermo Scientific). For total RNA extraction, the RNeasy^®^ Mini Kit (Qiagen, CA, USA) was used according to manufacturer's instructions. Briefly, the culture supernatants were subject to a high-speed centrifugation (14,000 rpm) for 10 min at 4 °C, the pellets were suspended in lysozyme-containing TE buffer and treated with RLT buffer with 1% β-mercaptoethanol for cell lysis. An on-column DNase treatment (RNase-free DNase, Qiagen) was included in the procedure to remove contaminant DNA, and RNA was eluted in 40 μl of RNase-free water. RNA yield and purity were determined by absorbance measurement at 260 nm and 280 nm using the NanoDrop 1000 spectrophotometer (Thermo Scientific). For a parallel qPCR quantification of the expression levels (and decay kinetics) along the time frame used, 5 μl of this total RNA was further used for cDNA generation (see below).

2.3. Bacterial mRNA preparation/purification {#sec0025}
--------------------------------------------

Eukaryotic, mitochondrial and bacterial rRNA were depleted by using the Ribo-Zero™ Gold rRNA Removal Kit (Epidemiology) (Illumina, CA, USA), according to manufacturer's instructions. Subsequently, the Dynabeads^®^ mRNA Purification Kit for mRNA Purification from Total RNA preps (LifeTechnologies) was used, with and adapted protocol, to pull the eukaryotic mRNA out of the samples, leaving only the bacterial mRNA. The obtained bacterial mRNA was concentrated in a final volume of 13 μl, by using the RNeasy^®^ MinElute™ Cleanup Kit (Qiagen, CA, USA), according to manufacturer's instructions. Bacterial mRNA quality and concentration were determined by the Bioanalyzer (Agilent) equipment, where the absence of rRNA readings reflects the purity of the mRNA.

2.4. RNA-seq {#sec0030}
------------

Bacterial mRNA-enriched samples were subjected to library construction (TruSeq Stranded mRNA sample preparation kit, Illumina) and sequencing on an Illumina MiSeq sequencer using a paired-end (2 × 75 bp) strategy (at least 15 M reads were dedicated *per* sample), according to manufacturer's instructions. FastQC analysis was used to assess reads quality and Bowtie2 was applied for mapping reads of each strain to the respective chromosome and plasmid DNA sequences obtained in a previous study ([@bib0050]). Cufflinks (version 2.1.1; <http://cufflinks.cbcb.umd.edu/>) tools were further applied to quantify the amount of transcripts of each chromosome and plasmid CDS normalized as fragments *per* kilobase of CDS *per* million mapped reads (FPKM), as previously described ([@bib0050]). Calculations of transcript amounts for each time point (before and after 10 and 30 min of rifampicin treatment) were based on two biological replicates. The use of a high throughput technology, such as the Illumina technology, is essential for the quantification of decaying mRNAs' expression levels ([@bib0160]) as it potentiates the capture of low expressed genes and extremely labile transcripts. In this study, transcript counts were obtained for the three experimental conditions (T~0~, T~10~ and T~30~) for \>99% of all annotated CDSs in both genomes.

2.5. cDNA generation and qPCR assays {#sec0035}
------------------------------------

In order to validate the obtained RNA-seq data, RNA decay kinetics was assessed in parallel by qPCR assays using cDNA samples generated at T~0~, T~10~ and T~30~, from both replicates of both strains, as previously described ([@bib0040]; [@bib0095]). Briefly, TaqMan^®^ RT Reagents (Applied Biosystems, Branchburg, USA) were used as follows: 2.5 μM of random hexamers, 5.5 mM MgCl2, 500 μM of each dNTP, 1 × RT Buffer, 0.8 U/μl RNase inhibitor and 1.25 U/μl MultiScribe RT, in a final reaction volume of 50 μl. Cycling conditions were: 10 min at 25 °C, 15 min at 42 °C and 5 min at 99 °C. cDNA was stored at −20 °C until use.

DNA from a 48 h (pi) chlamydial culture was extracted (as described above) and subjected to eight two-fold serial dilutions in DNase-free water, in order to produce the DNA standard curves for the expression quantification. The use of DNA standard curves allows the cross-comparison of the expression levels among genes at each time-point that could not be achieved by using cDNA standard curves, given that DNA represents equal amounts of each single copy gene. Primers for the 16SrRNA and 21 other genes selected for quantification purposes were design using the Primer Express software (Applied Biosystems). The qPCR assays were performed using the LightCycler^®^ 480 equipment, SYBR Green chemistry and optical plates and caps (Roche). The qPCR mixture consisted of 1 × LightCycler^®^ 480 SYBR Green I Master (Roche), 400 nM of each primer and 5 μl of each DNA (standard curves) or cDNA (samples), in a final volume of 25 μl. Plates included one standard curve for each gene, cDNA duplicates, and "no RT" controls.

Gene expression was normalized by dividing the mean value of raw qPCR duplicates by the respective mean value of the *16SrRNA*, for each condition (T~0~, T~10~ and T~30~), of both replicates of both strains. This strategy was used because *16SrRNA* was previously shown to be a stable gene, being a valuable resource for expression normalization in *C. trachomatis* ([@bib0040]).

2.6. mRNA half-life time (t~1/2~) analysis {#sec0040}
------------------------------------------

Each mRNA half-life time (t~1/2~) was calculated by using an adaptation of the "two-fold" decay step method ([@bib0230]) based on the fit of an exponential decay between values obtained at the first time-point (before rifampicin addition; T~0~) and the values calculated t minutes (10 min and/or 30 min) after the transcriptional arrest (T~1~), using the formula: t~1/2~ = -ln2/k; where the rate of decay rate (k) was estimated as follows: k = ln(T~1~/T~0~)/t. Therefore, it was also required to establish the appropriate time interval to correctly apply the formula, which was determined by performing an overall screening of the "decay profile" of each transcript, by considering its mean value of FPKM for the T~0~ (no treatment), T~10~ (10 min of antibiotic treatment) and T~30~ (30 min of antibiotic treatment). In that regard, the criteria applied were: *i*) if expression at T~0~ \> T~10~ \> T~30~, we used the interval with the highest slope (usually was the T~0~-T~10~); *ii*) if T~0~ \> T~10~ \< T~30~, we used the T~0~-T~10~ interval, whether T~0~\> T~30~ or T~0~ \< T~30~, because we assumed that at 30 min after rifampicin treatment the blockage effect of this antibiotic may not be as absolute as after 10 min; *iii*) if T~0~ \< T~10~\> T~30~, we used T~0~-T~30~, but only if T~0~ \> T~30~, otherwise we considered that there was no overall mRNA decay; and *iv*) if T~0~ \< T~10~ \< T~30~, we were not able to calculated mRNA decay at any interval, and therefore those transcripts were removed from the analysis.

Throughout the text, results were analyzed either in a gene-by-gene manner (assuming the gene designation of the D/UW3-CX genome annotation; NC_000117) or by functional categories (according to [@bib0145]; with some exceptions; Supplementary Table).

3. Results and discussion {#sec0045}
=========================

The main goal of the present study was to evaluate the whole transcriptome dynamics of *C. trachomatis* strains from the two biovars by using the RNA-seq technology. In particular, we aimed to: *i*) compare gene expression levels between four different serovar strains (D/CS637-11, E/CS1025-11, Ia/CS190-96 and L2b/CS19-08); *ii*) evaluate the decay rate of all mRNAs of two different biovar strains (E/CS1025-11 and L2b/CS19-08); and *iii*) correlate expression levels and half-life time (t~1/2~).

In a preliminary stage, we checked the reliability of the RNA-seq data through qPCR analysis of 22 transcripts to ensure that not only the initial mRNA levels of both strains were accurately determined by RNA-seq (T~0~), but also that the decay pattern of each transcript (T~0~ to T~10~ to T~30~) was also correctly determined. We obtained high reproducibility of the gene expression quantification results generated with the two distinct quantitative methods (R^2^ \> 0.88 for all comparisons) ([Fig. 1](#fig0005){ref-type="fig"}), which corroborates the suitability of the normalization strategy applied to the raw RNA-seq data.Fig. 1Relation of the expression levels acquired by qPCR (horizontal axis) and RNA-seq (vertical axis), for two C. trachomatis strains: L2b/CS19/08 (A) and E/CS1025/11 (B). Each dot represents the relation of the expression values obtained by the two methods, for the same transcript, of that particular strain. For each strain is shown that relation regarding three different sets of transcripts: 1) All transcripts quantified for each strain; 2) transcripts with a calculated half-life time ≤ 30 min; and 3) transcripts with a calculated half-life time ≤ 10 min. Both the linear correlation coefficient (R^2^) and the Pearson correlation coefficient (P) are shown in each graph, and indicating strong correlation.Fig. 1

3.1. Expression analysis between the two C. trachomatis biovars {#sec0050}
---------------------------------------------------------------

In this analysis, we compared the expression level of transcripts of *C. trachomatis* E/CS1025-11 and L2b/CS19-08 strains, and also of two additional strains (D/CS637-11 and Ia/CS190-96), for which RNA-seq data had been previously obtained ([@bib0050]). All four expression data sets were acquired at the mid-phase stage of the developmental cycle (when bacterial replication occurs) to ensure that the expression of the majority of the *C. trachomatis* genes is assessed ([@bib0030]; [@bib0150]).

Firstly, we looked at the genes presenting the highest level of expression at the mid-phase for each strain, and found a considerable parallelism between strains (all expression data is available at Supplementary Table). In fact, seven genes were found among the 10 most expressed, regardless of the strain. This set includes three genes (CT443/*omcB*, CT444/*omcA* and CT681/*ompA*) encoding major constituents of the outer membrane of this species, whose high expression at replication stage is not surprising, and also three poorly characterized genes (CT001, CT267, CT500), whose transcription performance warrants further investigation. Finally, the ORF2/*pgp8* genome region displayed high abundance of transcripts but this reflects the expression of its anti-sense sRNA ([@bib0010]; [@bib0095]). By extending the investigation to the top-50 most expressed genes, we observed that about 60--70% of those top ranked genes encode "Hypothetical proteins" (HPs) and proteins from the "Translation, ribosomal structure and biogenesis" functional category ([Fig. 2](#fig0010){ref-type="fig"}A). The proportion of genes from each of the remainder functional categories within the top-50 ranking never exceeded 6%.Fig. 2Distribution of the top-50 most expressed genes of each *C. trachomatis* strain. (A) Functional categories (colour coded) of the top-50 most expressed genes of the four strains. The proportion (in percentage) of each functional category is displayed in the vertical bars. (B) Venn's diagram depicting the overlap scenario, among strains, of their top-50 most expressed genes. The 22 genes found in all four top-50 ranks are displayed underneath the diagram and are listed by ORF number.Fig. 2

Furthermore, 22 genes were found in all four top-50 ranks ([Fig. 2](#fig0010){ref-type="fig"}B), where again the "HPs" were highly represented genes (7/22), followed by the "Translation, ribosomal structure and biogenesis" genes (5/22). All these 22 genes had already been pointed out as being highly expressed at the mid-phase stage of the developmental cycle of a trachoma biovar serovar E strain in a previous RNA-seq study ([@bib0150]). Considering our results on different serovar (and biovar) strains, these "core" genes certainly play a role in very conserved and essential mechanisms in *C. trachomatis*, at the mid-phase stage of the developmental cycle. Whereas for the members of the "Translation, ribosomal structure and biogenesis" functional category, this result may not be surprising, as at this stage there must be a tremendous demand of proteins playing a role in translation and metabolism, the high representation of HPs coding genes among the highly expressed genes is intriguing. In fact, *C. trachomatis* genes with unknown function are overrepresented in chlamydial genomes and are mostly genus- or species-specific ([@bib0120]; [@bib0260]), which make them certainly important for chlamydial biology ([@bib0265]; [@bib0280]), as corroborated by the present study.

Subsequently, we evaluated the global gene expression differences between strains by calculating the median of the gene-by-gene expression differences for each strain pair. We verified that the Ia/CS190/96 had the highest median value of expression difference, being 36% and 32% more expressed then the D/CS637-11 and the L2b/CS19-08 strains, respectively. On the other hand, these two latter strains presented only ∼1% variation in the median of expression differences. We then assessed the existence of functional categories for which the observed global trend (Ia/CS190--96 \> E/CS1025--11 \> L2b/CS19--08 \> D/CS637-11) is not applied. In this regard, the median of expression values was determined for each functional category, for each strain ([Fig. 3](#fig0015){ref-type="fig"}).Fig. 3Expression values by functional categories. The graph shows the medians of gene expression for 21 functional categories, for the four *C. trachomatis* strains (colour coded). Group sizes (displayed in the x axis) are similar among strains within each functional category. Asterisks (\*) indicate the functional categories for which statistically significant differences (*P* \< 0.05, one-way ANOVA test) were found between at least two strains. The expression median values displayed in the "Plasmid" functional category are a direct consequence of the tremendous transcript abundance of the sRNAs encoded in the antisense strand of two plasmid ORFs ([@bib0010]; [@bib0095]).Fig. 3

In agreement with the previous observation, both the L2b/CS19-08 and the D/CS637-11 strains presented the lowest median expression values across most functional categories, whereas Ia/CS190-96 was top-ranked for most of them (15/21). Nevertheless, there was a noteworthy exception as the E/CS1025-11 strain exhibited the highest expression medians for five functional categories, in particular in the "Plasmid genes" and "Cell envelope biogenesis, outer membrane" categories. When comparing the median values across functional categories, we found that four functional categories ("Secondary metabolites biosynthesis, transport, and catabolism", "Posttranslational modification, protein turnover, chaperones", "Translation, ribosomal structure and biogenesis", and "Plasmid genes") present higher medians than the remainder. As the plasmid encodes two highly expressed antisense sRNAs ([@bib0010]; [@bib0095]), the elevated expression values obtained for the "Plasmid genes" category are the result of the combined expression of both ORFs and the antisense sRNAs, and hence, the medians determined for this category are overestimated. There are five categories for which the medians were the lowest regardless the strain, namely, "DNA replication, recombination, and repair", "Coenzyme metabolism", "Cell division and chromosome partitioning", "Amino acid transport and metabolism", and "Incs or putative Incs". Of note, the expression differences observed between functional categories, within each strain, should be eyed with caution, as they may be a consequence of the time point of the developmental cycle at which the gene expression was evaluated and the growth conditions applied, which most certainly impact the biological needs of the bacterium at a given moment. For instance, the observation of *incs* among the less expressed genes at the mid-stage of the developmental cycle likely reflects the fact that the majority of *incs* shows an early-cycle profile of expression ([@bib0015]). On the other hand, expression differences between strains, within the same functional category, may suggest that dissimilar transcriptional regulation of functional-related genes is probably a determinant factor in the biological dissimilarities of the strains.

3.2. Half-life time analysis between different biovar strains {#sec0055}
-------------------------------------------------------------

Transcripts' degradation has an important role in the regulation of gene expression, where the coordinated action between the transcription initiation rate and the decay rate of each RNA, results in its steady-state abundance at a particular moment, under certain environmental conditions. Therefore, assessing transcripts stability may ultimately allow the inference of their role in the biology of bacteria. To date, several studies have already conducted global surveys of mRNA half-life times in several microorganisms ([@bib0285]; [@bib0035]; [@bib0130]; [@bib0020]; [@bib0025]; [@bib0160]; [@bib0220]; [@bib0175]; [@bib0060]), but none of them included an obligate intracellular pathogen. As such, we determined the t~1/2~ of the transcripts of two different biovar *C. trachomatis* strains (L2b/CS19-08 and E/CS1025-11) by measuring the transcript levels at 10 and 30 min post-treatment with the RNA polymerase blocking agent rifampicin. After defining the time interval that best fits the decay dynamics of each mRNA (see Section [2](#sec0010){ref-type="sec"} Materials and methods), we observed that the global mRNA half-life time between L2b/CS19-08 and E/CS1025-11 was very similar (no statistically significant difference was found, one-way ANOVA test), with median t~1/2~ values of 15 min and 17 min, respectively ([Fig. 4](#fig0020){ref-type="fig"}). Values of this magnitude had previously been reported for 5/10 genes with reliable T~1/2~ determination for the same-genus species, *C. pneumoniae* ([@bib0090]). In a previous study enrolling *Mycobacterium* ([@bib0220]), it was speculated that, for different species of this genus, the differences of the mean t~1/2~ values observed could be linked to the length of the developmental cycle, i.e., slower growths would correlate with higher mRNA stability. A previous study ([@bib0220]) argued that, the extended developmental cycle is a consequence of the strain's inability to quickly regulate mRNAs abundance. Further analyses with multiple strains with dissimilar growth rates is needed to verify if this assumption applies to *C. trachomatis* species since, although LGV strains typically grow faster than the trachoma biovar strains, we observed no significant differences in the growth rate of these strains during our experiments.Fig. 4Boxplots showing the distribution of mRNA t~1/2~ determined for different bacterial species: *Escherichia coli* ([@bib0035]), *Bacillus cereus* ([@bib0160]), *Mycobacterium tuberculosis* ([@bib0220]), and *C. trachomatis*, E/CS1025-11 and L2b/CS19-08 strains (this study). Regarding the global half-life time of these bacteria, statistically significant differences (one-way ANOVA test) were found between the L2b/CS19-08 strain and *E. coli*, *B. cereus*, and *M. tuberculosis* (*P* \< 0.01), whereas the E/CS1025-11 strain only differ from *E. coli* (*P* \< 0.05), probably due to the wider range of t~1/2~ of this *C. trachomatis* strain.Fig. 4

The range of t~1/2~ values obtained for the obligate intracellular *C. trachomatis* strains was strikingly wider (especially for E/CS1025-11) than those previously obtained for other bacteria ([@bib0035]; [@bib0160]; [@bib0220]), for which the t~1/2~ were also much lower, with medians of 9.3 min, 5.4 min and 2.6 min for *Mycobacterium tuberculosis* (facultative intracellular), *Escherichia coli* and *Bacillus cereus* (both extracellular), respectively ([Fig. 4](#fig0020){ref-type="fig"}). Previous studies regarding the Gram-negative *E. coli* and the Gram-positive *B. cereus* attributed the t~1/2~ differences to key ribonucleases that each bacteria possesses, a feature believed to distinguish the two Gram groups ([@bib0065]; [@bib0160]). However, when including our data from an obligate intracellular bacterium, strikingly larger differences between t~1/2~ are observed ([Fig. 4](#fig0020){ref-type="fig"}). In fact, the two studied free-living bacteria possess very low transcripts t~1/2~ medians (≤ 5.4 min), the facultative intracellular bacterium *M. tuberculosis* presents an intermediate transcripts' t~1/2~ median of ∼9.3 min, and the obligate intracellular *C. trachomatis* possesses much higher transcripts t~1/2~ medians (≥ 15 min). In support of this trend, the t~1/2~ median of *M. tuberculosis* contrasts with the one of its closely related free-living saprophyte *M. smegmatis* (5.2 min) ([@bib0220]). Altogether, although the presence/absence of particular ribonucleases can ultimately determine differences in mRNA decay dynamics, our observations suggest that a major factor underlying the t~1/2~ differences among bacteria is their life-style. For instance, the fact that obligate intracellular organisms may face less drastic environmental changes than free-living bacteria could underlie the slower turn-over rate of the transcripts abundance observed for *C. trachomatis*. However, data from future studies using more bacterial species, both Gram-positive and −negative, with distinct life-styles, will certainly help to elucidate if this observed trend is a sampling bias or if it mirrors the actual association between bacterial life-style and mRNA stability.

From the detailed analysis of t~1/2~ values detected for the two different biovar *C. trachomatis* strains, it was also striking to observe that both strains present a large number of highly stable genes ([Fig. 4](#fig0020){ref-type="fig"}). To investigate the nature of those genes, we looked in detail for the 100 genes with the highest t~1/2~ values for each strain. The top-100 most stable transcripts presented t~1/2~ values above 45 min for both strains, and most of them (\> 55%) belong to only four out of the 21 previously defined functional categories ([Fig. 5](#fig0025){ref-type="fig"}A). In particular, three of this highly represented categories (HPs, "Incs or putative Incs", and "Amino acid transport and metabolism") are shared between strains ([Fig. 5](#fig0025){ref-type="fig"}).Fig. 5Top-100 most stable mRNAs of two different biovar *C. trachomatis* strains. (A) Functional category (colour coded) of the top-100 most stable mRNAs of the two different biovar *C. trachomatis* strains, L2b/CS19-08 and E/CS1025-11, where the four most represented functional categories are discriminated. The number of genes from each functional category present in the top-100 is displayed. (B) Venn's diagram depicting the overlap between the L2b/CS19-08 (light red) and E/CS1025-11 (blue) strains of their top-100 most stable mRNAs, and of the mRNAs of the three functional categories ("HPs", "AA transp. & metab.", and "Incs") most represented in both top-100 rankings. Each number represents the absolute quantity of genes shared by the indicated strains in each comparison.Fig. 5

Although we found this parallelism at the functional category level ([Fig. 5](#fig0025){ref-type="fig"}A), the overlap was not so obvious at gene level as only 30 genes were shared by the two different biovar strains within this top-100 ranking. Of note, it must be stated that, despite the overrepresentation (30%) of "HPs" among the 100 most stable genes in both strains, this result must be interpreted with caution, as the "HPs" category is mostly composed by the unique *C. trachomatis* genes for which the biological function is yet to be established. For that reason, it is certainly highly heterologous in terms of gene function, encompassing representatives of several other categories. As such, any association between the huge mRNA stability and the scarce data available for some of them would be likely speculative. Besides all t~1/2~ determinations are performed through mathematical inferences, the t~1/2~ results beyond 30 min rely on extrapolation rather than on empirical observation of a two-fold decay during the studied time interval (0--30 min post-treatment). Thus, we further focused our analysis on transcripts presenting t~1/2~ values lower than 30 min for both strains (n = 525). Nonetheless, the pairwise comparison of the transcripts' t~1/2~ revealed lack of correlation between the two strains (Pearson correlation coefficient, P = 0.546; R^2^ = 0.2978). As these t~1/2~ discrepancies can eventually be a result of the excessive sensitivity of the mathematical formula used to model the mRNA decay curve, we looked at the mRNA stability trends at functional category level, as this effect may be buffered. In fact, this approach is corroborated by previous genome-wide studies, which suggested some degree of correlation between gene function and mRNAs' t~1/2~ in several organisms ([@bib0285]; [@bib0300]; [@bib0020]). We observed statistically significant differences of t~1/2~ values between strains for three functional categories ([Fig. 6](#fig0030){ref-type="fig"}): "Translation, ribosomal structure and biogenesis" (*P* \< 0.001), "Energy production and conversion" (*P* \< 0.05), and "DNA replication, recombination, and repair" (*P* \< 0.05). Interestingly, for both strains, the "DNA replication, recombination, and repair" was also found to be one of the categories with the lowest medians of gene expression, whereas the "Translation, ribosomal structure and biogenesis" category was found to be one with the highest medians of gene expression, (see section "3.1 Expression analysis between the two *C. trachomatis* biovars"). However, both categories present statistically significant t~1/2~ differences between *C. trachomatis* strains from the two biovars, meaning that, regardless the mRNA abundance, both groups of housekeeping genes are differently regulated by these strains at the mid-stage of the developmental cycle. Taking into account the properties of these functional categories, the observed differences may account for dissimilar metabolic performance between two biovars' strains potentially impacting the well-known development and pathogenicity dissimilarities. We also checked for significant differences in the t~1/2~ values between functional categories within each strain, and found that, regardless of the biovar, there were indeed some statistically significant differences (*P* \< 0,05) ([Fig. 6](#fig0030){ref-type="fig"}). This could suggest that transcripts acting in specific networks need to be maintained for longer periods, likely in order to guarantee that the production of specific proteins is not interrupted. This feature seems to be contingent on the species rather than on the biovar.Fig. 6Half-life time by functional categories. The chart displays the half-life time values of the 525 transcripts yielding t~1/2~ \< 30 min for both strains, according to their functional category (in different colours). For each functional category, t~1/2~ values for L2b/CS19-08 are represented on the left, whereas t~1/2~ values for E/CS1025-11 are represented on the right. The horizontal small dashes represent the median of the t~1/2~ values. Statistically significant differences of t~1/2~ values between functional categories (within the same strain) were found, and those shared by both strains are indicated with asterisks (*P* \< 0.05; one-way ANOVA test).Fig. 6

3.3. Comparison between expression level and t~1/2~ {#sec0060}
---------------------------------------------------

Finally, we evaluated whether the expression level at the mid-stage of the developmental cycle (T~0~) of a given transcript correlates with its t~1/2~ value. This analysis was performed for two different biovar strains (L2b/CS19-08 and E/CS1025-11). We found a lack of correlation between the stability of a transcript and its level of expression, as corroborated by the Pearson correlation coefficients calculated for the same pairs of comparisons ([Fig. 7](#fig0035){ref-type="fig"}). Even when exclusively taking into account genes with the lowest t~1/2~ (\< 10 min) ([Fig. 7](#fig0035){ref-type="fig"}A.3 and B.3), i.e., those less prone to be biased by both the sensitivity of the formula applied for the t~1/2~ calculations and the period of time used, there was still no correlation between the level of expression and t~1/2~ values. Previous studies with different bacteria had also found no correlation or found a negative correlation between these two parameters (steady-state transcript abundance and t~1/2~) ([@bib0035]; [@bib0160]; [@bib0220]), where the latter was suggested to be a consequence of the bacterial need for a quick turnover of highly abundant transcripts. We raise the hypothesis that, for an organism with a unique biphasic and multi-stage life-cycle as *C. trachomatis*, the overall lack of correlation may be just a consequence of the tight transcriptional control that is continuously operating during such a complex development. Another fact contributing to this trend may be the intricate host-pathogen interactions that take place for an obligate intracellular pathogen, which implies its continuous and dynamic adaptation. Nevertheless, it is noteworthy that we found sporadic cases in which a negative correlation was observed, although only four genes (CT157, CT219, CT421.2 and CT559) were common to both different biovar strains (analysis strictly focused on the first 100 upper and bottom ranked genes). Whereas CT421.2 and CT559 presented high expression levels and low mRNA stability, the opposite scenario was observed for CT219 and CT157. On the other hand, one study ([@bib0035]) also found a group of highly abundant transcripts that were highly stable, which does not fit the mentioned "negative correlation". Curiously, although we found some transcripts following this pattern, none of them was shared by the two biovars (data not shown). As such, a highly abundant mRNA may or may not be as susceptible to degradation as a scarce mRNA, so transcript abundance *per si* does not seem to be a trigger for a quick-degradation.Fig. 7Pairwise relation between the genes' expression level, determined at the mid-stage of the developmental cycle (T0), and their t~1/2~. The three graphs, both in panel A and panel B, represent the relation obtained for three different groups of genes of L2b/CS19-08 and E/CS1025-11 strains, respectively. Those three groups of genes were defined according to the t~1/2~ they exhibited: 1) all transcripts with calculated t~1/2~; 2) transcripts with t~1/2~ ≤ 30 min; and 3) transcripts with t~1/2~ ≤ 10 min. Both the linear correlation coefficient (R^2^) and the Pearson correlation coefficient (P) are shown in each graph.Fig. 7

Overall, this study constitutes a first attempt to integrate and understand the global mRNA production and decay dynamics in *C. trachomatis*. While this exploratory work emphasizes that it would be valuable to conduct similar studies for other bacterial pathogens, the preliminary data generated here for *C. trachomatis* highlights important research questions that should be followed in this subject. For instance, it would be interesting to investigate a putative correlation between the growth rate and transcripts' stability, and to get insights into the potential differential decay rates of transcripts belonging to polycistronic operons. Still, our data suggests that the specific interplay between transcripts' production and degradation is likely driven by complex transcriptional networks that still need to be disclosed, and where specific RNA-binding proteins and small RNAs may play key roles, a notion that is becoming more consolidated (reviewed in [@bib0290] and [@bib0200]).
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